INNATE PHARMA news, videos and press releases - Page 2
For more news please use our advanced search feature.
INNATE PHARMA - More news...
INNATE PHARMA - More news...
- Innate Pharma Highlights Proprietary Tetra-specific ANKET® NK Cell Engager IPH6501 at the EHA 2023 Congress
- Innate Pharma Highlights Proprietary Tetra-specific ANKET® NK Cell Engager IPH6501 at the EHA 2023 Congress
- Innate Pharma: SAR’579 / IPH6101 Receives FDA Fast Track Designation in the US for the Treatment of Hematological Malignancies
- SAR’579 / IPH6101 Receives FDA Fast Track Designation in the US for the Treatment of Hematological Malignancies
- Number of Shares and Voting Rights of Innate Pharma as of June 1, 2023
- Number of Shares and Voting Rights of Innate Pharma as of June 1, 2023
- Innate Pharma Highlights Phase 1/2 Dose Escalation Safety and Preliminary Efficacy of Sanofi Developed First NK Cell Engager SAR’579 / IPH6101 in R/R AML
- Innate Pharma Highlights Phase 1/2 Dose Escalation Safety and Preliminary Efficacy of Sanofi Developed First NK Cell Engager SAR’579 / IPH6101 in R/R AML
- Innate Pharma to Participate in Upcoming Investor Conferences
- Innate Pharma to Participate in Upcoming Investor Conferences
- Innate Pharma to Present IPH6501 Preclinical Data at The EHA 2023 Congress
- Innate Pharma to Present IPH6501 Preclinical Data at The EHA 2023 Congress
- Outcome of Innate Pharma’s 2023 Annual General Meeting
- Outcome of Innate Pharma’s 2023 Annual General Meeting
- Innate Pharma Reports First Quarter 2023 Financial Results and Business Update
- Innate Pharma Reports First Quarter 2023 Financial Results and Business Update
- Number of shares and voting rights of Innate Pharma as of May 1, 2023
- Number of shares and voting rights of Innate Pharma as of May 1, 2023
- Innate Pharma Highlights Clinical Abstracts Selected for ASCO 2023 Annual Meeting
- Innate Pharma Announces Conference Call and Webcast for Q1 Business Update
- Innate Pharma Announces Conference Call and Webcast for Q1 Business Update
- Innate Pharma Highlights Clinical Abstracts Selected for ASCO 2023 Annual Meeting
- Innate Pharma Establishes a New At-The-Market (“ATM”) Program on Nasdaq
- Innate Pharma Establishes a New At-The-Market (“ATM”) Program on Nasdaq
- Innate Pharma to Participate in Upcoming Investor Conference
- Innate Pharma to Participate in Upcoming Investor Conference
- Number of Shares and Voting Rights of Innate Pharma as of April 1, 2023
- Number of Shares and Voting Rights of Innate Pharma as of April 1, 2023
- Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023
- Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 12, 2023
